ArticleDrugs in context2022

Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE.

Ngan Thi Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.